BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33871895)

  • 21. A Novel KMT2A-ARHGEF12 Fusion Gene Identified in a High-Grade B-cell Lymphoma.
    Jung HS; Lin F; Wolpaw A; Reilly AF; Margolskee E; Luo M; Wertheim GB; Li MM
    Cancer Genet; 2020 Aug; 246-247():41-43. PubMed ID: 32805689
    [No Abstract]   [Full Text] [Related]  

  • 22. Extramedullary relapse of
    Aldoss I; Song JY
    Blood; 2018 May; 131(22):2507. PubMed ID: 29853461
    [No Abstract]   [Full Text] [Related]  

  • 23. Identification of a novel KMT2A-SEPT14 fusion in acute myeloid leukemia.
    Nguyen D; Haley L; Pallavajjala A; Gojo I; Ning Y
    Leuk Lymphoma; 2018 Jan; 59(1):265-267. PubMed ID: 28573893
    [No Abstract]   [Full Text] [Related]  

  • 24. KMT2A (MLL) rearrangements observed in pediatric/young adult T-lymphoblastic leukemia/lymphoma: A 10-year review from a single cytogenetic laboratory.
    Peterson JF; Baughn LB; Pearce KE; Williamson CM; Benevides Demasi JC; Olson RM; Goble TA; Meyer RG; Greipp PT; Ketterling RP
    Genes Chromosomes Cancer; 2018 Nov; 57(11):541-546. PubMed ID: 30203571
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Kato S; Kubota Y; Sekiguchi M; Watanabe K; Shinozaki-Ushiku A; Takita J; Hiwatari M
    Pediatr Hematol Oncol; 2021 Apr; 38(3):281-289. PubMed ID: 33150819
    [No Abstract]   [Full Text] [Related]  

  • 26. [Biological microchip for establishing the structure of fusion transcripts involving MLL in children with acute leukemia].
    Nasedkina TV; Ikonnikova AY; Tsaur GA; Karateeva AV; Ammour YI; Avdonina MA; Karachunskii AI; Zasedatelev AS
    Mol Biol (Mosk); 2016; 50(6):968-977. PubMed ID: 28064313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mature B cell acute lymphoblastic leukaemia with KMT2A-MLLT3 transcripts in children: three case reports and literature reviews.
    Cui Y; Zhou M; Zou P; Liao X; Xiao J
    Orphanet J Rare Dis; 2021 Jul; 16(1):331. PubMed ID: 34330316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KMT2A-CBL fusion in rapidly progressive myeloid disorder.
    Chaum M; Vail E; Schreck R; Lorber J; Eno CC
    Cancer Genet; 2022 Aug; 266-267():90-92. PubMed ID: 35933946
    [No Abstract]   [Full Text] [Related]  

  • 29. Lineage switch to acute myeloid leukemia during induction chemotherapy for early T-cell precursor acute lymphoblastic leukemia with the translocation t(6;11)(q27;q23)/KMT2A-AFDN: A case report.
    Permikin Z; Popov A; Verzhbitskaya T; Riger T; Plekhanova O; Makarova O; Froňková E; Trka J; Meyer C; Marschalek R; Tsaur G; Fechina L
    Leuk Res; 2022 Jan; 112():106758. PubMed ID: 34864370
    [No Abstract]   [Full Text] [Related]  

  • 30. B-cell lymphoblastic lymphoma with cutaneous involvement and a KMT2A gene rearrangement.
    Kemps PG; Cleven AHG; van Wezel T; van Eijk R; Bot FJ; Veelken H; van Balen P; Kerkhoffs JH
    Am J Hematol; 2020 Nov; 95(11):1427-1429. PubMed ID: 32243611
    [No Abstract]   [Full Text] [Related]  

  • 31. Prognostic value of minimal residual disease measured by fusion-gene transcript in infants with KMT2A-rearranged acute lymphoblastic leukaemia treated according to the MLL-Baby protocol.
    Tsaur G; Popov A; Riger T; Kustanovich A; Solodovnikov A; Shorikov E; Demina A; Verzhbitskaya T; Streneva O; Makarova O; Lapotentova E; Aleinikova O; Miakova N; Boichenko E; Kondratchik K; Ponomareva N; Karachunskiy A; Roumiantsev A; Fechina L
    Br J Haematol; 2021 Jun; 193(6):1151-1156. PubMed ID: 33583020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants.
    Fazio G; Bardini M; De Lorenzo P; Grioni A; Quadri M; Pedace L; Corral Abascal L; Palamini S; Palmi C; Buldini B; Vinti L; Parasole R; Barisone E; Zecca M; Favre C; Locatelli F; Conter V; Rizzari C; Valsecchi MG; Biondi A; Cazzaniga G
    Blood; 2021 Apr; 137(14):1980-1984. PubMed ID: 33512459
    [No Abstract]   [Full Text] [Related]  

  • 33. Subclonality and prenatal origin of RAS mutations in KMT2A (MLL)-rearranged infant acute lymphoblastic leukaemia.
    Emerenciano M; Barbosa Tda C; de Almeida Lopes B; Meyer C; Marschalek R; Pombo-de-Oliveira MS
    Br J Haematol; 2015 Jul; 170(2):268-71. PubMed ID: 25613690
    [No Abstract]   [Full Text] [Related]  

  • 34. A novel KMT2A-USO1 fusion gene-induced de novo secondary acute myeloid leukaemia in a patient initially diagnosed with acute promyelocytic leukaemia.
    Jin W; Chen L; Liu Y; Chen Q; Zhao M; Tan Y; Zhang W; Song H; Weng X; Mi J; Chen S; Chen Z; Li J; Wang K
    Br J Haematol; 2021 Jan; 192(1):e32-e36. PubMed ID: 33216970
    [No Abstract]   [Full Text] [Related]  

  • 35. Acute myeloid leukemia with t(10;11)(p11-12;q23.3): Results of Russian Pediatric AML registration study.
    Zerkalenkova E; Lebedeva S; Kazakova A; Tsaur G; Starichkova Y; Timofeeva N; Soldatkina O; Aprelova E; Popov A; Ponomareva N; Baidun L; Meyer C; Novichkova G; Maschan M; Maschan A; Marschalek R; Olshanskaya Y
    Int J Lab Hematol; 2019 Apr; 41(2):287-292. PubMed ID: 30624859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Umbilical cord blood transplantation can overcome the poor prognosis of KMT2A-MLLT3 acute myeloid leukemia and can lead to good GVHD-free/relapse-free survival.
    Tong J; Zhang L; Liu H; Xu X; Zheng C; Yao W; Zhu X; Tang B; Wan X; Song K; Zhang X; Sun G; Sun Z
    Ann Hematol; 2021 May; 100(5):1303-1309. PubMed ID: 33469688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cryptic and atypical KMT2A-USP2 and KMT2A-USP8 rearrangements identified by mate pair sequencing in infant and childhood leukemia.
    Blackburn PR; Smadbeck JB; Znoyko I; Webley MR; Pitel BA; Vasmatzis G; Xu X; Greipp PT; Hoppman NL; Ketterling RP; Baughn LB; Lindsey KG; Schandl CA; Wolff DJ; Peterson JF
    Genes Chromosomes Cancer; 2020 Jul; 59(7):422-427. PubMed ID: 32196814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD49f protein expression varies among genetic subgroups of B lymphoblastic leukemia and is distinctly low in KMT2A-rearranged cases.
    Collins K; Cardinali JL; Mnayer LO; DiGiuseppe JA
    Cytometry B Clin Cytom; 2021 Mar; 100(2):243-248. PubMed ID: 31894899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased risk of adverse acute myeloid leukemia after anti-CD19-targeted immunotherapies in
    Fournier E; Inchiappa L; Delattre C; Pignon JM; Danicourt F; Bemba M; Roche-Lestienne C; Daudignon A; Decool G; Roumier C; Dumezy F; Fournier L; Grardel N; Preudhomme C; Duployez N
    Leuk Lymphoma; 2019 Jul; 60(7):1827-1830. PubMed ID: 30616415
    [No Abstract]   [Full Text] [Related]  

  • 40. FLT3
    Hyrenius-Wittsten A; Pilheden M; Falqués-Costa A; Eriksson M; Sturesson H; Schneider P; Wander P; Garcia-Ruiz C; Liu J; Ågerstam H; Hultquist A; Lilljebjörn H; Stam RW; Järås M; Hagström-Andersson AK
    Leukemia; 2019 Sep; 33(9):2310-2314. PubMed ID: 30953031
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.